THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
STAKEHOLDER FORUM 2015 - Registration now open
This year's IMI Stakeholder Forum will take place on Monday 15 June in Brussels, Belgium.
Join us to learn about IMI's achievements so far and give input on our future activities and plans!
- 22/05/2015 : RT @IMI_LifeTrain: New @IMI_LifeTrain case study online: @OrionPharma's CrossTraining - learning from colleagues, http://t.co/NTXVMDrwML ht…
- 22/05/2015 : RT @AD_PREVENT: What a week #bbc interview, @IMI_EPAD assembly with @IMI_JU @JanssenEMEA @AlzheimerEurope all playing huge part. #DAW2015 m…
- 21/05/2015 : US @HouseCommerce committee votes unanimously in favour of #Cures2015, which mentions IMI http://t.co/WsBX9Moiy6 @ECcures